Drug Profile
IDP 73152
Alternative Names: IDP-73152; IDP-73152 mesylateLatest Information Update: 28 Apr 2018
Price :
$50
*
At a glance
- Originator Ildong Pharmaceutical
- Class Antibacterials
- Mechanism of Action Peptide deformylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 28 Apr 2018 No recent reports of development identified for phase-I development in Bacterial-infections(In volunteers) in South Korea (PO)
- 04 Apr 2016 Phase I development is ongoing in South Korea
- 01 Jan 2014 Ildong Pharmaceutical completes a phase I trial in Healthy volunteers in South Korea (NCT01904318)